View in EDS HTML Full Text PDF Full Text

The Safety Profile of Pridopidine, a Novel Sigma-1 Receptor Agonist for the Treatment of Huntington's Disease.

Saved in:
Bibliographic Details
Title: The Safety Profile of Pridopidine, a Novel Sigma-1 Receptor Agonist for the Treatment of Huntington's Disease.
Authors: Goldberg YP; Prilenia Therapeutics B.V., Naarden, The Netherlands., Navon-Perry L; Prilenia Therapeutics B.V., Naarden, The Netherlands., Cruz-Herranz A; Prilenia Therapeutics B.V., Naarden, The Netherlands., Chen K; Prilenia Therapeutics B.V., Naarden, The Netherlands., Hecker-Barth G; GHB Hecker-Barth Biopharma Consulting GmbH, Konstanz, Germany., Spiegel K; Prilenia Therapeutics B.V., Naarden, The Netherlands., Cohen Y; Prilenia Therapeutics B.V., Naarden, The Netherlands., Niethammer M; North Shore University Hospital, Northwell Health, Manhasset, NY, USA., Tan AM; Prilenia Therapeutics B.V., Naarden, The Netherlands.; Department of Neurology, Yale University School of Medicine, New Haven, CT, USA., Schuring H; Prilenia Therapeutics B.V., Naarden, The Netherlands., Geva M; Prilenia Therapeutics B.V., Naarden, The Netherlands., Hayden MR; Prilenia Therapeutics B.V., Naarden, The Netherlands. Michael.Hayden@prilenia.com.; Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, V5Z 4H4, Canada. Michael.Hayden@prilenia.com.
Source: CNS drugs [CNS Drugs] 2025 May; Vol. 39 (5), pp. 485-498. Date of Electronic Publication: 2025 Mar 07.
Publication Type: Journal Article
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9431220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1934 (Electronic) Linking ISSN: 11727047 NLM ISO Abbreviation: CNS Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40055280
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The Safety Profile of Pridopidine, a Novel Sigma-1 Receptor Agonist for the Treatment of Huntington's Disease.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Goldberg+YP%22">Goldberg YP</searchLink>; Prilenia Therapeutics B.V., Naarden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Navon-Perry+L%22">Navon-Perry L</searchLink>; Prilenia Therapeutics B.V., Naarden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Cruz-Herranz+A%22">Cruz-Herranz A</searchLink>; Prilenia Therapeutics B.V., Naarden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Chen+K%22">Chen K</searchLink>; Prilenia Therapeutics B.V., Naarden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Hecker-Barth+G%22">Hecker-Barth G</searchLink>; GHB Hecker-Barth Biopharma Consulting GmbH, Konstanz, Germany.<br /><searchLink fieldCode="AU" term="%22Spiegel+K%22">Spiegel K</searchLink>; Prilenia Therapeutics B.V., Naarden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Cohen+Y%22">Cohen Y</searchLink>; Prilenia Therapeutics B.V., Naarden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Niethammer+M%22">Niethammer M</searchLink>; North Shore University Hospital, Northwell Health, Manhasset, NY, USA.<br /><searchLink fieldCode="AU" term="%22Tan+AM%22">Tan AM</searchLink>; Prilenia Therapeutics B.V., Naarden, The Netherlands.; Department of Neurology, Yale University School of Medicine, New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Schuring+H%22">Schuring H</searchLink>; Prilenia Therapeutics B.V., Naarden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Geva+M%22">Geva M</searchLink>; Prilenia Therapeutics B.V., Naarden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Hayden+MR%22">Hayden MR</searchLink>; Prilenia Therapeutics B.V., Naarden, The Netherlands. Michael.Hayden@prilenia.com.; Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, V5Z 4H4, Canada. Michael.Hayden@prilenia.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229431220%22">CNS drugs</searchLink> [CNS Drugs] 2025 May; Vol. 39 (5), pp. 485-498. <i>Date of Electronic Publication: </i>2025 Mar 07.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9431220 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1934 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211727047%22">11727047 </searchLink><i>NLM ISO Abbreviation: </i>CNS Drugs <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40055280
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40263-025-01171-x
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 485
    Titles:
      – TitleFull: The Safety Profile of Pridopidine, a Novel Sigma-1 Receptor Agonist for the Treatment of Huntington's Disease.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Goldberg YP
      – PersonEntity:
          Name:
            NameFull: Navon-Perry L
      – PersonEntity:
          Name:
            NameFull: Cruz-Herranz A
      – PersonEntity:
          Name:
            NameFull: Chen K
      – PersonEntity:
          Name:
            NameFull: Hecker-Barth G
      – PersonEntity:
          Name:
            NameFull: Spiegel K
      – PersonEntity:
          Name:
            NameFull: Cohen Y
      – PersonEntity:
          Name:
            NameFull: Niethammer M
      – PersonEntity:
          Name:
            NameFull: Tan AM
      – PersonEntity:
          Name:
            NameFull: Schuring H
      – PersonEntity:
          Name:
            NameFull: Geva M
      – PersonEntity:
          Name:
            NameFull: Hayden MR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2025 May
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1179-1934
          Numbering:
            – Type: volume
              Value: 39
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: CNS drugs
              Type: main
ResultId 1